EN DE
STOCK COMPARISON

Empro Group Inc. Ordinary shares vs McKesson: Fair Value & Quality

Both stocks run through our valuation models. Here is how Empro Group Inc. Ordinary shares (EMPG) and McKesson (MCK) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Empro Group Inc. Ordinary shares trades at $17.36 versus a fair value of $1.80 (-90%), while McKesson trades at $870 versus $819 (-6%).
Empro Group Inc. Ordinary shares
EMPG · USD · Healthcare
-90%
upside to fair value
overvalued
Price$17.36
Fair Value$1.80
Quality66/100
McKesson
MCK · USD · Health Care
-6%
upside to fair value
fairly valued
Price$870
Fair Value$819
Quality66/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Empro Group Inc. Ordinary sharesMcKesson
Valuation
192.9×P/E (TTM)21.0×
26.08×P/S (TTM)0.23×
EV/EBITDA13.9×
PEG1.57×
Dividend yield0.4%
Dividend per share$3.17
Profitability
14%Net margin1%
36%Operating margin2%
66%Return on equity
16%Return on assets5%
Growth
142%Revenue growth (YoY)6%
-2.0%Avg. growth/yr (3Y)13.4%
Avg. growth/yr (5Y)11.1%
Balance & size
0.78×Debt / equity
$143MMarket cap$94B
weakGrowth qualityhealthy

Empro Group Inc. Ordinary shares leads: 4 to 3 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Empro Group Inc. Ordinary sharesof which business quality 61 · market factors 63 McKessonof which business quality 65 · market factors 63
ProfitabilityMargins and returns on capital today
89
49
Quality GrowthAre margins and returns improving?
100
65
CashflowEarnings quality: real cash, not paper profit
9
47
Fin. StrengthBalance sheet, leverage, solvency risk
61
72
InvestmentDisciplined investing over empire-building
34
76
Low VolatilityCalm price path (market factor)
32
83
MomentumPrice trend over the last 3–12 months (market factor)
63
51
52W MomentumDistance to the 52-week high (market factor)
98
62
Net IssuanceBuybacks instead of dilution
82
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Empro Group Inc. Ordinary shares

DCF Models$2.54
Earnings-Based$1.80
Dividend Discount$0.19
Multiples$1.69
Asset-Based$0.12
Economic Profit$1.03
Growth Earnings$2.43

17 of 17 models see the stock below the current price.

McKesson

DCF Models$955
Earnings-Based$444
Dividend Discount$57.26
Multiples$848
Growth DCF$922
Economic Profit$497
Growth Earnings$708

13 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Empro Group Inc. Ordinary shares
Bear $0.63Fair Value $1.80Bull $2.28
$17.36 = current price (white tick)
McKesson
Bear $605Fair Value $819Bull $1,034
$870 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Empro Group Inc. Ordinary shares · Healthcare

Quality score66 · Top 25%
Fair value upside-90% · bottom 25%

McKesson · Health Care

Quality score66 · Top 25%
Fair value upside-6% · above median

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees McKesson as the less overvalued of the two: Empro Group Inc. Ordinary shares trades at $17.36 versus a fair value of $1.80 (-90%), while McKesson trades at $870 versus $819 (-6%).

Empro Group Inc. Ordinary shares has the higher quality score (66/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.